Search

Equasens

Fechado

37.8 0.4

Visão Geral

Variação de preço das ações

24h

Atual

Mín

37.55

Máximo

37.85

Indicadores-chave

By Trading Economics

Rendimento

-1.8M

17M

Vendas

7.2M

116M

P/E

Médio do Setor

16.213

Rendimento de Dividendos

3.08

Margem de lucro

14.879

Funcionários

1,400

EBITDA

178M

116M

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

3.08%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-24M

583M

Abertura anterior

37.4

Fecho anterior

37.8

Equasens Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de out. de 2025, 17:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion

1 de nov. de 2025, 12:56 UTC

Ganhos

Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ

1 de nov. de 2025, 12:56 UTC

Ganhos

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 de nov. de 2025, 12:20 UTC

Ganhos

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 de nov. de 2025, 12:19 UTC

Ganhos

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

1 de nov. de 2025, 08:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

1 de nov. de 2025, 08:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

1 de nov. de 2025, 00:10 UTC

Ganhos

Trouble on The Strip -- Barrons.com

31 de out. de 2025, 23:09 UTC

Ganhos

Review & Preview: October Surprise -- Barrons.com

31 de out. de 2025, 22:44 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 de out. de 2025, 21:25 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk

31 de out. de 2025, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update

31 de out. de 2025, 21:12 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ

31 de out. de 2025, 21:12 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ

31 de out. de 2025, 21:12 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ

31 de out. de 2025, 20:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com

31 de out. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

31 de out. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

31 de out. de 2025, 20:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

31 de out. de 2025, 20:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement

31 de out. de 2025, 20:22 UTC

Ganhos

Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com

31 de out. de 2025, 20:02 UTC

Ganhos

Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com

31 de out. de 2025, 19:55 UTC

Conversa de Mercado

Crude Futures Fall for Third Straight Month -- Market Talk

31 de out. de 2025, 19:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer: FTC Granted Early Termination of Waiting Period >PFE

31 de out. de 2025, 19:54 UTC

Aquisições, Fusões, Aquisições de Empresas

Pfizer: Receives Early Clearance From FTC for Metsera Acquisition

31 de out. de 2025, 19:26 UTC

Conversa de Mercado

U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk

31 de out. de 2025, 18:30 UTC

Ganhos

These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com

31 de out. de 2025, 18:23 UTC

Conversa de Mercado

Gold Edges Lower for the Day, Closes October Positive -- Market Talk

31 de out. de 2025, 18:09 UTC

Ganhos

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

31 de out. de 2025, 18:08 UTC

Ganhos

Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com

Equasens Previsão

Consenso de Avaliação

By TipRanks

0 ratings

0

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat